CD177 and neoplasm: Collectively, these results support the mechanistic model of the P-bi-TAT action being initiated at an integrin cell surface receptor to interfere with tumor cell proliferation and tumor-associated angiogenesis, as well as to disrupt functions of apoptosis resistance and DNA repair pathways.